# Regulatory Readiness Report — CyberCom Platform
**Program 10, Phase 7 — Documentation**  
**Date:** 2026-06-29  
**Prepared by:** Chief Compliance Officer, Chief Information Security Officer, Enterprise Architect  
**Classification:** Confidential

---

## Executive Summary

CyberCom Platform has completed all software-level regulatory readiness requirements for Release 2. The platform architecture enforces privacy, security, and clinical safety at the code level. External regulatory filings, legal agreements, and jurisdiction-specific approvals are deployment-time activities outside software scope.

**Regulatory Readiness Posture: SOFTWARE COMPLETE — EXTERNAL FILINGS REQUIRED**

---

## 1. Data Privacy Compliance

### GDPR (EU General Data Protection Regulation)

| Requirement | Status | Implementation |
|-------------|--------|----------------|
| Lawful basis for processing | ✅ Architecture | Consent model in `CyConsent` |
| Right to access (Subject Access Request) | ✅ Implemented | Export endpoint for patient data |
| Right to erasure (Right to be Forgotten) | ✅ Implemented | Soft delete + anonymization pipeline |
| Data minimization | ✅ Architecture | No excessive data collection in models |
| Purpose limitation | ✅ Architecture | Data classification enforced per model |
| Storage limitation | ✅ Implemented | Retention policy in `platform/compliance/` |
| Integrity and confidentiality | ✅ Implemented | Encryption at rest + in transit |
| Data breach notification | ✅ Architecture | Incident response in `platform/security/` |
| Cross-border transfer controls | ✅ Architecture | Tenant-scoped data residency |
| DPA / Data Processing Agreement template | ⚠ External | Legal department to execute per customer |
| DPO appointment | ⚠ External | Customer-side requirement |

### PDPL (Saudi Arabia Personal Data Protection Law)

| Requirement | Status | Implementation |
|-------------|--------|----------------|
| Data localization (KSA residency) | ✅ Infrastructure | Deployment to KSA region supported |
| Explicit consent for health data | ✅ Implemented | Consent captured and stored |
| Sensitive health data protections | ✅ Implemented | Encryption + access control |
| NDMO notification for breaches | ⚠ External | Operational process required |
| Cross-border transfer restrictions | ✅ Architecture | Tenant configuration controls data region |

### Jordan Health Data Regulations

| Requirement | Status | Implementation |
|-------------|--------|----------------|
| MOH reporting capability | ✅ Implemented | Reporting engine in CyInsight |
| Patient data localization | ✅ Infrastructure | On-premise deployment supported |
| Electronic health record standards | ✅ Implemented | FHIR R4 + HL7 v2 compliant |

---

## 2. Clinical Standards Compliance

### IEC 62304 — Medical Device Software Lifecycle

| Class | Status | Notes |
|-------|--------|-------|
| Class A (no injury risk) | ✅ Applicable | Admin/reporting modules |
| Class B (non-serious injury) | ⚠ Assessment required | Clinical decision support |
| Class C (serious injury risk) | ⚠ Assessment required | Drug interaction enforcement |

**Action Required:** Formal IEC 62304 classification assessment by qualified person before CE marking.

### ISO 13485 — Quality Management

- ⚠ External: Formal QMS implementation required for medical device certification
- Software development practices comply with ISO 13485 spirit:
  - Version control (git) ✅
  - Code review process ✅
  - Test documentation ✅
  - Change control (Conventional Commits + PR review) ✅

### HL7 FHIR R4 Conformance

- ✅ CapabilityStatement published at `/fhir/R4/metadata`
- ✅ Required FHIR resources supported (Patient, Encounter, Observation, Condition, etc.)
- ⚠ FHIR conformance testing against national IGs (Jordan, KSA, UAE) required at deployment

---

## 3. Security & Audit Compliance

### ISO 27001 — Information Security

| Domain | Status |
|--------|--------|
| Access control | ✅ RBAC + ABAC + MFA |
| Cryptography | ✅ TLS 1.3, AES-256, RS256 JWT |
| Operations security | ✅ Monitoring, logging, backup |
| Supplier relationships | ⚠ Vendor security assessments required |
| Incident management | ✅ Incident response framework |
| Business continuity | ✅ DR procedures documented |

### SOC 2 Type II

- ✅ Trust Service Criteria implemented in software:
  - Security ✅ | Availability ✅ | Confidentiality ✅ | Processing Integrity ✅ | Privacy ✅
- ⚠ External: Third-party SOC 2 Type II audit engagement required (planned Q4 2026)

### HIPAA (US Health Insurance Portability and Accountability Act)

- ✅ Technical safeguards: access control, audit logs, encryption, automatic logoff
- ✅ PHI handling architecture compliant
- ⚠ External: BAA (Business Associate Agreement) required per US customer
- ⚠ External: HIPAA risk assessment documentation required

---

## 4. Regional Regulatory Requirements

| Market | Regulator | Key Requirements | Status |
|--------|-----------|-----------------|--------|
| Jordan | JFDA / MOH | HIS registration, MOH reporting | ⚠ Filing required |
| Saudi Arabia | SFDA / NDMO | NDMO data classification, SFDA HIS approval | ⚠ Filing required |
| UAE | MOH / DOH / HAAD | DOH HIS approval, ADHICS compliance | ⚠ Filing required |
| Egypt | MOHP | Data residency, MOHP approval | ⚠ Filing required |
| International | Varies | CE marking (EU), FDA clearance (US) | ⚠ Future requirement |

---

## 5. Regulatory Readiness Checklist

### Software Complete ✅
- [x] Multi-tenant data isolation (PostgreSQL RLS + model-level)
- [x] Immutable audit trail (hash-chained, tamper-evident)
- [x] Role-based access control (RBAC + ABAC + OPA)
- [x] Multi-factor authentication (TOTP, WebAuthn, Push)
- [x] Data encryption (in transit + at rest + field-level)
- [x] Consent management (capture, store, export)
- [x] Patient data export (Subject Access Request)
- [x] Data anonymization pipeline
- [x] Retention policy enforcement
- [x] FHIR R4 interoperability
- [x] ICD-11, SNOMED, LOINC, LOINC terminology

### External Actions Required ⚠
- [ ] Data Protection Officer (DPO) appointment
- [ ] Data Processing Agreements executed with all customers
- [ ] SOC 2 Type II audit engagement
- [ ] Penetration testing (annual)
- [ ] IEC 62304 formal classification
- [ ] Regional regulatory filings per market
- [ ] FHIR conformance testing vs national IGs
- [ ] Drug interaction database licensing
- [ ] Clinical validation by licensed clinicians

---

## 6. Open Items Log

| ID | Item | Owner | Target Date |
|----|------|-------|-------------|
| REG-001 | SOC 2 Type II audit | CCO | Q4 2026 |
| REG-002 | Penetration test | CISO | Pre-pilot |
| REG-003 | IEC 62304 assessment | Quality Manager | Q3 2026 |
| REG-004 | Jordan MOH registration | CCO | Q3 2026 |
| REG-005 | Saudi SFDA filing | CCO | Q4 2026 |
| REG-006 | Drug DB licensing (Micromedex/FDB) | CIO | Pre-pilot |
| REG-007 | FHIR conformance test (JO IG) | CTO | Q3 2026 |
| REG-008 | DPO appointment (EU customers) | CCO | Per customer |
